207 related articles for article (PubMed ID: 17185751)
1. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor.
Shraga-Heled N; Kessler O; Prahst C; Kroll J; Augustin H; Neufeld G
FASEB J; 2007 Mar; 21(3):915-26. PubMed ID: 17185751
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
3. Modulation of vascular endothelial growth factor receptors in melanocytes.
Kim EJ; Park HY; Yaar M; Gilchrest BA
Exp Dermatol; 2005 Aug; 14(8):625-33. PubMed ID: 16026585
[TBL] [Abstract][Full Text] [Related]
4. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines.
Lantuéjoul S; Constantin B; Drabkin H; Brambilla C; Roche J; Brambilla E
J Pathol; 2003 Jul; 200(3):336-47. PubMed ID: 12845630
[TBL] [Abstract][Full Text] [Related]
5. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF.
Neufeld G; Kessler O; Herzog Y
Adv Exp Med Biol; 2002; 515():81-90. PubMed ID: 12613545
[TBL] [Abstract][Full Text] [Related]
6. Neuropilin-1 forms complexes with vascular endothelial growth factor receptor-2 during megakaryocytic differentiation of UT-7/TPO cells.
Ohsaka A; Hirota-Komatsu S; Shibata M; Komatsu N
Biochem Biophys Res Commun; 2009 Dec; 390(4):1171-6. PubMed ID: 19857463
[TBL] [Abstract][Full Text] [Related]
7. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects.
Yang XH; Man XY; Cai SQ; Yao YG; Bu ZY; Zheng M
Biochem Biophys Res Commun; 2006 Oct; 349(1):31-8. PubMed ID: 16930552
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A
Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477
[TBL] [Abstract][Full Text] [Related]
9. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
Cébe-Suarez S; Grünewald FS; Jaussi R; Li X; Claesson-Welsh L; Spillmann D; Mercer AA; Prota AE; Ballmer-Hofer K
FASEB J; 2008 Aug; 22(8):3078-86. PubMed ID: 18467594
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.
Kawamura H; Li X; Harper SJ; Bates DO; Claesson-Welsh L
Cancer Res; 2008 Jun; 68(12):4683-92. PubMed ID: 18559514
[TBL] [Abstract][Full Text] [Related]
11. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis.
Man XY; Yang XH; Cai SQ; Yao YG; Zheng M
Mol Med; 2006; 12(7-8):127-36. PubMed ID: 17088944
[TBL] [Abstract][Full Text] [Related]
12. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells.
Hsieh SH; Ying NW; Wu MH; Chiang WF; Hsu CL; Wong TY; Jin YT; Hong TM; Chen YL
Oncogene; 2008 Jun; 27(26):3746-53. PubMed ID: 18223683
[TBL] [Abstract][Full Text] [Related]
13. Neuropilins in physiological and pathological angiogenesis.
Staton CA; Kumar I; Reed MW; Brown NJ
J Pathol; 2007 Jul; 212(3):237-48. PubMed ID: 17503412
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability.
Becker PM; Waltenberger J; Yachechko R; Mirzapoiazova T; Sham JS; Lee CG; Elias JA; Verin AD
Circ Res; 2005 Jun; 96(12):1257-65. PubMed ID: 15920019
[TBL] [Abstract][Full Text] [Related]
15. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors.
Kärpänen T; Heckman CA; Keskitalo S; Jeltsch M; Ollila H; Neufeld G; Tamagnone L; Alitalo K
FASEB J; 2006 Jul; 20(9):1462-72. PubMed ID: 16816121
[TBL] [Abstract][Full Text] [Related]
16. [Advances of research on vascular endothelial growth factor receptors in epidermal neoplasm].
YANG P; ZHENG M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):422-6. PubMed ID: 19693983
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies.
Chung JY; Song Y; Wang Y; Magness RR; Zheng J
J Clin Endocrinol Metab; 2004 May; 89(5):2484-90. PubMed ID: 15126581
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.
Guttmann-Raviv N; Shraga-Heled N; Varshavsky A; Guimaraes-Sternberg C; Kessler O; Neufeld G
J Biol Chem; 2007 Sep; 282(36):26294-305. PubMed ID: 17569671
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
20. Parapoxvirus of red deer in New Zealand encodes a variant of viral vascular endothelial growth factor.
Ueda N; Inder MK; Wise LM; Fleming SB; Mercer AA
Virus Res; 2007 Mar; 124(1-2):50-8. PubMed ID: 17109982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
